Adicet Bio to present Phase 1 prula-cel data in systemic lupus erythematosus on Sept. 28, 2026 webcast

Bitget2026/09/25 20:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Adicet Bio set a Sept. 28, 2026 webcast to disclose Phase 1 data for prula-cel in systemic lupus erythematosus.
Results have not been presented yet; the update is scheduled for a future presentation.
Readout targets patients with lupus with or without lupus nephritis, a potential expansion into autoimmune disease beyond oncology programs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adicet Bio Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609251600BIZWIRE_USPR_____20260925_BW951649) on September 25, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Adicet Bio to present Phase 1 prula-cel data in systemic lupus erythematosus on Sept. 28, 2026 webcast

You may also like

Crypto prices